Cover Image
市場調查報告書

人類乳突病毒(HPV)相關的癌症:全球臨床實驗檢討

Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 298074
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
Back to Top
人類乳突病毒(HPV)相關的癌症:全球臨床實驗檢討 Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月19日 內容資訊: 英文 121 Pages
簡介

本報告提供人類乳突病毒(HPV)相關的癌症的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中人類乳突病毒(HPV)相關的癌症的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

E7各國的臨床實驗:腫瘤科臨床實驗中人類乳突病毒(HPV)相關的癌症的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與人類乳突病毒(HPV)相關的癌症治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Transgene SA
    • Oryx GmbH & Co. KG
    • North Shore-Long Island Jewish Health System, Inc.
    • Lee's Pharmaceutical Holdings Limited
    • ISA Pharmaceuticals B.V.
    • EyeGene, Inc.
  • 主要大學·研究機關·醫院臨床實驗概要
    • The University of Hong Kong
    • Sidney Kimmel Comprehensive Cancer Center
    • Odense University Hospital
    • University Hospital, Essen
    • Vanderbilt-Ingram Cancer Center
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Eastern Cooperative Oncology Group
    • National Taiwan University Hospital
    • National Cancer Institute
    • University of California, Davis

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2041CTIDB

GlobalData's clinical trial report, "Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014" provides data on the Human papillomavirus (HPV) Associated Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Human papillomavirus (HPV) Associated Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Human papillomavirus (HPV) Associated Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Human papillomavirus (HPV) Associated Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Human papillomavirus (HPV) Associated Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Human papillomavirus (HPV) Associated Cancer
    • Nov 04, 2013: Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study
    • Apr 16, 2013: PDS Biotechnology's New Cancer Immunotherapy PDS0101 Set To Enter Clinical Trials
    • Feb 19, 2013: Advaxis Announces Brown University Oncology Group To Conduct Phase I/II Trial Of ADXS-HPV In Anal Cancer
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Transgene SA
      • Clinical Trial Overview of Transgene SA
      • Oryx GmbH & Co. KG
      • Clinical Trial Overview of Oryx GmbH & Co. KG
      • North Shore-Long Island Jewish Health System, Inc.
      • Clinical Trial Overview of North Shore-Long Island Jewish Health System, Inc.
      • Lee's Pharmaceutical Holdings Limited
      • Clinical Trial Overview of Lee's Pharmaceutical Holdings Limited
      • ISA Pharmaceuticals B.V.
      • Clinical Trial Overview of ISA Pharmaceuticals B.V.
      • EyeGene, Inc.
      • Clinical Trial Overview of EyeGene, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • Odense University Hospital
      • Clinical Trial Overview of Odense University Hospital
      • University Hospital, Essen
      • Clinical Trial Overview of University Hospital, Essen
      • Vanderbilt-Ingram Cancer Center
      • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of California, Davis
      • Clinical Trial Overview of University of California, Davis
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Transgene SA, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oryx GmbH & Co. KG, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore-Long Island Jewish Health System, Inc., 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lee's Pharmaceutical Holdings Limited, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ISA Pharmaceuticals B.V., 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EyeGene, Inc., 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Essen, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014*

List of Figures

  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top